Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer

The Lancet

Volumn 339, Issue 8786, 1992, Pages 139-143

  Bieche I ^a   Champeme M H ^a   Matifas, F ^a   Lidereau, R ^a   Hacene K ^a   Callahan, R ^b  

^a CENTRE RENÉ HUGUENIN   (France)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CHROMOSOME 7; DNA DETERMINATION; FEMALE; GENETIC ANALYSIS; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; SUPPRESSOR GENE; SURVIVAL RATE;

EID: 84920218738     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(92)90208-K     Document Type: Article

References (40)

1. Distal deletion of chromosome 1p in ductal carcinoma of the breast
2. Loss of heterozygosity of the L-myc oncogene in human breast tumors
3. DF-3 tumor-associated antigen gene is frequently altered in primary human breast carcinomas
4. Presence of two members of c-erbA receptor gene family (c-erbAβ and c-erbA2) in smallest region of somatic homozygosity on chromosome 3p21-3p25 in human breast cancer
5. Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level
6. Loss of heterozygosity in human ductal breast tumors indicates a recessive mutation on chromosome 13
7. Allele loss on short arm of chromosome 17 in breast cancers
8. Loss of heterozygosity on chromosomes 17 and 18 in breast cancer carcinoma: two additional regions identified
9. Human colorectal cancer: high frequency of deletions at chromosome 1p35
10. Clonal allele loss in gastrointestinal cancers
11. A genetic model for colorectal tumorigenesis
12. Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung
13. Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung
14. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma
15. Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix
16. Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas
17. Loss of 3p or 11p alleles is associated with testicular cancer tumors
18. Loss of heterozygosity for genes on 11p and the clinical course of patients with lung carcinoma
19. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas
20. Loss of genes on the short arm of chromosome 11 in bladder cancer
21. Loss of alleles at loci on chromosome 13 in primary gastric cancers
22. Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder
23. Allele loss from chromosome 17 in ovarian cancer
24. Cytogenetic and molecular biologic alterations in human breast cancer: a review
25. Characterisation of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases
26. Sequence of MET proto-oncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors
27. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product
28. Molecular cloning of a new transforming gene from a chemically transformed human cell line
29. Characterisation of the rearranged tpr-met oncogene breakpoint
30. A closely linked genetic marker for cystic fibrosis
31. Histological grading and prognosis in breast cancer A study on 1409 cases of which 359 have been followed for 15 years
32. EORTC Breast Cooperative Group revision of the standards for the assessment of hormone receptor in human breast cancer
33. Tenth international workshop of human gene mapping
34. Mutations in human breast cancer: an overview
35. TaqI RFLP of the TGFα gene in breast cancer
36. Metastasis suppressor genes
37. Localisation of genes involved in invasion and metastases on human chromosome 7
38. Relation of cytogenetic abnormalities and clinical outcome in metastatic melanoma
39. Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia